Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting the Efficacy of Paclitaxel Plus Ramucirumab in Advanced Gastric Cancer.

NCT06490055 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06490055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06490055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting the Efficacy of Paclitaxel Plus Ramucirumab in Advanced Gastric Cancer.
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
July 1, 2025
Enrollment
162 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, gastric cancer, paclitaxel, ramucirumab